Therapeutic targeting of gastrointestinal cancer stem cells.


Journal

Regenerative medicine
ISSN: 1746-076X
Titre abrégé: Regen Med
Pays: England
ID NLM: 101278116

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 27 4 2019
medline: 4 4 2020
entrez: 27 4 2019
Statut: ppublish

Résumé

Gastrointestinal cancers remain a tremendous burden on society. Despite advances in therapy options, including chemotherapy and radiation, cancer mortality from recurrences and metastases occur frequently. Cancer stem cells (CSCs) drive disease recurrence and metastasis, as these cells are uniquely equipped to self-renew and evade therapy. Therefore, cancer eradication requires treatment strategies that target CSCs in addition to differentiated cancer cells. This review highlights current literature on therapies targeting CSCs in gastrointestinal cancer.

Identifiants

pubmed: 31025613
doi: 10.2217/rme-2018-0146
pmc: PMC6886570
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-343

Subventions

Organisme : NCI NIH HHS
ID : P30 CA056036
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA204481
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA206026
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008562
Pays : United States

Références

Nature. 2006 Dec 7;444(7120):756-60
pubmed: 17051156
Biomed Res Int. 2015;2015:635745
pubmed: 26649310
Curr Mol Pharmacol. 2008 Jun;1(2):93-105
pubmed: 19079736
Nat Med. 1998 Sep;4(9):1046-52
pubmed: 9734398
Asian Pac J Cancer Prev. 2012;13(5):1809-17
pubmed: 22901127
Immunol Cell Biol. 2017 Aug;95(7):620-629
pubmed: 28356569
Cancer Sci. 2011 May;102(5):991-8
pubmed: 21281402
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63
pubmed: 17548814
Oncol Res Treat. 2014;37(11):666-8, 670-2
pubmed: 25427584
Cell Mol Life Sci. 2015 Sep;72(18):3411-24
pubmed: 25967289
J Natl Cancer Inst. 2006 Dec 20;98(24):1777-85
pubmed: 17179479
Nature. 2013 Sep 19;501(7467):338-45
pubmed: 24048066
Hepatology. 2005 Nov;42(5):1127-36
pubmed: 16114043
Cancer Biol Med. 2015 Sep;12(3):163-74
pubmed: 26487961
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
pubmed: 12629218
N Engl J Med. 2012 Jun 7;366(23):2171-9
pubmed: 22670903
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Nature. 2007 Jan 4;445(7123):111-5
pubmed: 17122771
Cancer Res. 2015 Oct 15;75(20):4416-28
pubmed: 26282173
Curr Med Chem. 2011;18(27):4185-94
pubmed: 21838687
BMC Cancer. 2013 Jul 08;13:336
pubmed: 23829413
Oncotarget. 2017 Feb 21;8(8):13545-13559
pubmed: 28088790
Gastroenterology. 2007 Jun;132(7):2542-56
pubmed: 17570225
J Immunol. 2013 Mar 1;190(5):2381-90
pubmed: 23345327
Sci Adv. 2017 Jun 21;3(6):e1700090
pubmed: 28691093
Nat Med. 1997 Jul;3(7):730-7
pubmed: 9212098
J Immunol. 2009 Mar 15;182(6):3530-9
pubmed: 19265131
Clin Cancer Res. 2014 Feb 15;20(4):837-46
pubmed: 24323901
Eur J Cancer. 2012 May;48(7):997-1003
pubmed: 22445247
J Int Med Res. 2015 Apr;43(2):204-16
pubmed: 25631875
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):795-9
pubmed: 4016789
Nature. 2004 Nov 18;432(7015):396-401
pubmed: 15549107
PLoS One. 2013 Apr 08;8(4):e60715
pubmed: 23593291
Nat Cell Biol. 2010 May;12(5):468-76
pubmed: 20418870
Cancer Sci. 2016 Jan;107(1):5-11
pubmed: 26362755
Clin Cancer Res. 2015 Jan 1;21(1):60-7
pubmed: 25231399
Blood. 2008 Dec 15;112(13):4793-807
pubmed: 19064739
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1480-5
pubmed: 16432235
Oncoimmunology. 2018 May 7;7(7):e1440169
pubmed: 29900044
Science. 2018 Mar 23;359(6382):1361-1365
pubmed: 29567707
Cancer Treat Rev. 2018 Jan;62:50-60
pubmed: 29169144
Clin Cancer Res. 2008 Aug 1;14(15):4971-80
pubmed: 18676772
Biochim Biophys Acta. 2012 Dec;1823(12):2130-5
pubmed: 22906540
Cancer Res. 1981 May;41(5):1967-72
pubmed: 7214365
Leukemia. 2003 Aug;17(8):1454-63
pubmed: 12886231
J Immunol. 2015 Oct 15;195(8):4010-9
pubmed: 26363055
Bioessays. 2009 Oct;31(10):1038-49
pubmed: 19708024
Int J Mol Sci. 2017 Jul 05;18(7):null
pubmed: 28678194
Ann Oncol. 2006 Nov;17(11):1620-4
pubmed: 16600978
Nat Rev Cancer. 2012 Jan 12;12(2):133-43
pubmed: 22237392
Nat Rev Clin Oncol. 2015 Aug;12(8):445-64
pubmed: 25850553
Cancer Res. 2005 Oct 15;65(20):9328-37
pubmed: 16230395
Int Immunol. 2009 Jul;21(7):793-801
pubmed: 19491215
Int J Biol Sci. 2015 Jan 21;11(3):284-94
pubmed: 25678847
Nat Rev Cancer. 2008 Mar;8(3):167-79
pubmed: 18256617
Br J Haematol. 2007 Jul;138(2):186-95
pubmed: 17593025
Oncotarget. 2017 Feb 21;8(8):13600-13619
pubmed: 28099140
J Cell Biochem. 2012 Dec;113(12):3643-52
pubmed: 22711554
Cancer Sci. 2016 Nov;107(11):1556-1562
pubmed: 27575869
Cancer Res. 2012 Apr 1;72(7):1853-64
pubmed: 22473314
Nat Rev Cancer. 2013 Oct;13(10):714-26
pubmed: 24060863
Cell Stem Cell. 2007 Sep 13;1(3):313-23
pubmed: 18371365
Gastric Cancer. 2014 Jan;17(1):13-25
pubmed: 23563919
Cancer Invest. 2008 Jun;26(5):535-42
pubmed: 18568776
Oncogene. 2014 Jan 30;33(5):665-70
pubmed: 23318432
Nature. 1994 Feb 17;367(6464):645-8
pubmed: 7509044
Lancet. 1993 Mar 20;341(8847):725-6
pubmed: 8095628
Nature. 2009 Apr 9;458(7239):780-3
pubmed: 19194462
Cancer Cell. 2011 Mar 8;19(3):387-400
pubmed: 21397861
Mol Carcinog. 2007 Jan;46(1):1-14
pubmed: 16921491
Theranostics. 2017 Sep 13;7(16):3948-3961
pubmed: 29109790
Oncotarget. 2012 May;3(5):559-67
pubmed: 22643847
Cancer Res. 2013 Mar 15;73(6):1855-66
pubmed: 23319806
Tumour Biol. 2016 May;37(5):5735-42
pubmed: 26864589
Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):928-42
pubmed: 15234026
Nature. 2007 Jan 4;445(7123):106-10
pubmed: 17122772
Cell Stem Cell. 2014 Mar 6;14(3):275-91
pubmed: 24607403
Mol Cancer. 2006 Dec 02;5:67
pubmed: 17140455
J Immunol. 2009 Jun 1;182(11):7287-96
pubmed: 19454726
Oncogene. 2006 Mar 16;25(12):1696-708
pubmed: 16449977
Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):237-41
pubmed: 8990192
Sci Transl Med. 2015 Nov 18;7(314):314ra186
pubmed: 26582901
Stem Cells Int. 2016;2016:1740936
pubmed: 27418931
Oncogene. 2016 Oct 27;35(43):5619-5628
pubmed: 27157616
Cancer Immunol Immunother. 2012 Jul;61(7):979-89
pubmed: 22120758
Cancer Lett. 2013 Mar 1;330(1):84-95
pubmed: 23196060
Oncoimmunology. 2015 Jun 5;4(9):e1036212
pubmed: 26405602
Annu Rev Cell Dev Biol. 2007;23:675-99
pubmed: 17645413
Lancet Oncol. 2014 Jul;15(8):829-40
pubmed: 24954781
Invest New Drugs. 2014 Aug;32(4):739-45
pubmed: 24668033
J Clin Oncol. 2015 Dec 20;33(36):4284-92
pubmed: 26527777
Nature. 2013 Sep 19;501(7467):328-37
pubmed: 24048065
Nature. 2012 Jan 18;481(7381):306-13
pubmed: 22258609

Auteurs

Jonathan Stem (J)

Departments of Surgery, Sidney, 1020 Locust St, JAH368, Philadelphia, PA 19107, USA.

John C Flickinger (JC)

Pharmacology & Experimental Therapeutics, Sidney, 1020 Locust St, JAH368, Philadelphia, PA 19107, USA.

Dante Merlino (D)

Pharmacology & Experimental Therapeutics, Sidney, 1020 Locust St, JAH368, Philadelphia, PA 19107, USA.

Ellen M Caparosa (EM)

Departments of Surgery, Sidney, 1020 Locust St, JAH368, Philadelphia, PA 19107, USA.
Pharmacology & Experimental Therapeutics, Sidney, 1020 Locust St, JAH368, Philadelphia, PA 19107, USA.

Adam E Snook (AE)

Pharmacology & Experimental Therapeutics, Sidney, 1020 Locust St, JAH368, Philadelphia, PA 19107, USA.

Scott A Waldman (SA)

Pharmacology & Experimental Therapeutics, Sidney, 1020 Locust St, JAH368, Philadelphia, PA 19107, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH